Castle Biosciences earnings were -$19.4M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest CSTL earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.1M, down 85.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CSTL reported annual earnings of -$24.2M, with -232.4% growth. The next CSTL earnings date is Nov 2, 2026.
What were Castle Biosciences's earnings last quarter?
On CSTL's earnings call on Jul 30, 2026, Castle Biosciences (NASDAQ: CSTL) reported Q2 2026 earnings per share (EPS) of -$0.07, up 143.75% year over year. Total CSTL earnings for the quarter were -$2.06 million. In the same quarter last year, Castle Biosciences's earnings per share (EPS) was $0.16.
The next CSTL earnings call is Nov 2, 2026. Add CSTL to your watchlist to be reminded of Castle Biosciences's next earnings date.
Is Castle Biosciences profitable or losing money?
As of the last Castle Biosciences earnings report, Castle Biosciences is currently losing money. Castle Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$19.42 million, a 105.1% increase year over year.
What was CSTL's earnings growth in the past year?
As of Castle Biosciences's earnings date in Jul 30, 2026, Castle Biosciences's earnings has grown year over year. CSTL earnings in the past year totalled -$19.42 million.
What are Castle Biosciences's earnings expectations?
The current EPS estimate for Castle Biosciences's earnings report in Nov 2, 2026 is -$0.38.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.